Drug Profile
Amlodipine/losartan/rosuvastatin - Hanmi Pharmaceuticals
Alternative Names: Amosartan Q; Losartan/amlodipine/rosuvastatin; Rosuvastatin/losartan/amlodipineLatest Information Update: 02 Jun 2022
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Biphenyl compounds; Dihydropyridines; Fluorobenzenes; Heart failure therapies; Imidazoles; Ischaemic heart disorder therapies; Pyrimidines; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hyperlipidaemia; Hypertension